Displacement of 6-Amino-9-(2-carboxy-4-((6-(4-(4-(4-(4-(3-carboxy-6-(4-(trifluoromethyl)phenyl)-naphthalen-1-yl)phenyl)piperidin-1-yl)-butyl)-1H-1,2,3...

Basic Information

ID: ALA4426502

Type: Binding

Description: Displacement of 6-Amino-9-(2-carboxy-4-((6-(4-(4-(4-(4-(3-carboxy-6-(4-(trifluoromethyl)phenyl)-naphthalen-1-yl)phenyl)piperidin-1-yl)-butyl)-1H-1,2,3-triazol-1-yl)hexyl)carbamoyl)-phenyl)-3-iminio-5-sulfo-3H-xanthene-4-sulfonate from human P2Y14R expressed in CHO cells at 3 uM measured after 15 mins by flow cytometric analysis

Format: BAO_0000219

Organism: Homo sapiens

Cell type: CHO

Target: Purinergic receptor P2Y14(ALA4518)

Document: ALA4425123

Displacement of 6-Amino-9-(2-carboxy-4-((6-(4-(4-(4-(4-(3-carboxy-6-(4-(trifluoromethyl)phenyl)-naphthalen-1-yl)phenyl)piperidin-1-yl)-butyl)-1H-1,2,3-triazol-1-yl)hexyl)carbamoyl)-phenyl)-3-iminio-5-sulfo-3H-xanthene-4-sulfonate from human P2Y14R expressed in CHO cells at 3 uM measured after 15 mins by flow cytometric analysis: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4426502

Inhibition

Total(42)

Compound Summary

Parent Molecular Weight	ALogP	Polar Surface Area
475.51	7.36	7.36
440.50	4.47	4.47
466.59	5.72	5.72
439.52	4.35	4.35
430.53	4.83	4.83
438.53	5.07	5.07
431.52	4.22	4.22
508.50	5.67	5.67
466.54	4.97	4.97
454.53	4.78	4.78
388.47	3.98	3.98
492.50	5.79	5.79
508.50	5.67	5.67
430.55	5.15	5.15
414.47	4.36	4.36
480.61	6.06	6.06
454.53	4.78	4.78
442.49	4.91	4.91
458.95	5.42	5.42
503.40	5.53	5.53
454.53	4.26	4.26
509.43	5.59	5.59
424.50	4.77	4.77
439.52	4.35	4.35
442.49	4.91	4.91
460.48	5.04	5.04
484.56	4.78	4.78
452.56	5.33	5.33
464.53	5.51	5.51
430.53	4.83	4.83
468.51	4.46	4.46
464.98	5.48	5.48
426.48	3.56	3.56
458.95	5.42	5.42
468.51	4.46	4.46
425.49	4.16	4.16
466.59	5.89	5.89
460.48	5.04	5.04
442.49	4.91	4.91
492.50	5.79	5.79
510.64	6.34	6.34
454.53	4.78	4.78